In vivo protection against endotoxin by plasma high density lipoprotein
about
Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infectionsHypocholesterolemia in sepsis and critically ill or injured patientsApolipoprotein A-I and CancerHDL in sepsis - risk factor and therapeutic approachAdvances in the Study of the Antiatherogenic Function and Novel Therapies for HDLAnimal models and the tumor microenvironment: studies of tumor-host symbiosisThe cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsApolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid productionMembrane Insertion for the Detection of Lipopolysaccharides: Exploring the Dynamics of Amphiphile-in-Lipid AssaysEffect of angiotensin II type 2 receptor-interacting protein on adipose tissue function via modulation of macrophage polarizationApolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties.Effect of high-density lipoprotein on lipopolysaccharide-induced alveolar bone resorption in rats.Characterisation of lipid profiles in dogs with parvoviral enteritis.High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.Microbial translocation and cardiometabolic risk factors in HIV infection.Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue.Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.Lipoproteins: When size really matters.Egg intake during carbohydrate restriction alters peripheral blood mononuclear cell inflammation and cholesterol homeostasis in metabolic syndrome.Changes in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxinThe apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.NKT cells in sepsis.Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewTargeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo.Endotoxemia is associated with an increased risk of incident diabetes.The lipid-bound apolipoprotein A-I cysteine mutant (N74C) inhibits the activation of NF-κB, JNK and p38 in endotoxemic mice and RAW264.7 cells.Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice.Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization.Novel therapies for sepsis: antiendotoxin therapies.Intravenous lipids for preterm infants: a review.Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in miceDeletion of scavenger receptor A gene in mice resulted in protection from septic shock and modulation of TLR4 signaling in isolated peritoneal macrophages.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides
P2860
Q24298291-4F0B823B-9242-458E-823E-55B8CD884C2BQ24562428-42946366-CE6C-4CE3-ACBA-8E2C4D6BA69FQ24802517-31AC6C28-26F0-4751-83F2-78368717B186Q26776188-288A83A4-7B9B-47B1-B7A0-7CDE47E8BD83Q26777964-E50CFF8F-4292-401D-88DD-89260718E413Q26801507-6BAB36F8-4B0B-4E55-B730-CA00FA37AEC3Q26853538-13CC6487-EAF4-4A2E-A367-7BCF0467A00EQ28388695-AC443FE5-E458-407D-A507-2DC4B6E85A51Q28509152-D49BD714-120B-4CC4-AD16-2EE060567830Q28552464-4303B4BE-A9BB-45B0-BCD6-36743953C7EDQ28584994-C9EA5E37-239B-4682-A7F4-9712C9650543Q30427768-73F8DC25-CD85-46BC-93B4-44CC5CDC06B4Q30859659-EC675A0D-1F8D-456F-8184-80A75B399319Q33375813-7D074321-313D-42CD-94D1-D0DA36CC8FD9Q33565025-7A7E56DA-4CAD-4AC8-99B1-D1B722B46BCFQ33713895-FB3BF1BB-E51E-4457-9132-DAEED5E18770Q33751658-734BED02-07C8-4680-9CEB-5C639215BC72Q33810018-EA7755DE-3433-429C-A890-BC0391AF5760Q33929735-D9870175-FFAC-47B0-9189-55D1B52A937DQ33947533-E55517E7-7FDE-44DD-87BA-31640605C0A7Q33963273-5196D939-EAFB-4E5E-A12D-A50735CF7502Q33997983-208984D7-DD31-47D4-B929-EE47C1151CC0Q34053131-46A174E6-168E-4434-839C-05584BE777F1Q34069439-9B761699-08D0-4C80-9536-D4412CEF41B4Q34181607-E9DEB5FA-FA31-4C93-878F-2742CC11AD18Q34189487-1F72B7D4-4D68-467F-8F5D-1B4A6437CDD8Q34207487-6E971BE7-D1F3-4003-8A1C-667105C32F62Q34238630-2441DA7D-AD85-496E-9478-539FAF577BABQ34395133-E9A1954B-746F-4283-A2CB-D5BCA5148064Q34507178-8F441E36-A2DA-467E-BF2E-CD146D3D70B1Q34516452-4EF7C0AA-BC0E-4C88-8B66-136663709AEFQ34656242-E18997EE-6C43-4371-8502-FC76BEA9FDBAQ34731730-077ABE40-6FD6-4531-832D-AD54974BE52DQ34992608-479C8811-4F41-48B0-8D5E-63913F384E26Q35011910-07F5003C-AAA9-44AB-86E8-BA790C7135ACQ35076642-E449E749-1F81-44E7-B5AE-C0E2DD38FCF8Q35138400-F65887A1-0CDE-42D3-A8A7-0711351260E0Q35146730-6CCFB369-6465-4DF1-B5FE-AAA41171ACC7Q35176262-4E2D8F43-6ECC-45E0-8C3A-9BAF71943F61Q35378360-B44AE3AA-E60A-4E96-95FE-FCA783925D7E
P2860
In vivo protection against endotoxin by plasma high density lipoprotein
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
In vivo protection against endotoxin by plasma high density lipoprotein
@ast
In vivo protection against endotoxin by plasma high density lipoprotein
@en
type
label
In vivo protection against endotoxin by plasma high density lipoprotein
@ast
In vivo protection against endotoxin by plasma high density lipoprotein
@en
prefLabel
In vivo protection against endotoxin by plasma high density lipoprotein
@ast
In vivo protection against endotoxin by plasma high density lipoprotein
@en
P2093
P2860
P356
P1476
In vivo protection against endotoxin by plasma high density lipoprotein
@en
P2093
P2860
P304
12040-12044
P356
10.1073/PNAS.90.24.12040
P407
P577
1993-12-01T00:00:00Z